CATALENT PHARMA: To Respond to FDA Warning Letter Over Facility
October 3, 2008
Catalent Pharma Solutions, Inc. intends to cooperate with the U.S. Food and Drug Administration in response to the Warning Letter concerning the Company’s North Raleigh Sterile Technologies facility.
In the second quarter of fiscal 2008, the FDA initiated an inspection, or…